Pfizer submits new paediatric data for Lipitor to EMEA
Pfizer Inc has submitted paediatric data for Lipitor (atorvastatin) to the European Medicines Agency (EMEA). Pfizer has also developed a new chewable form of Lipitor, including a paediatric-appropriate 5 mg dose, which is part of this submission.
2009-11-20 -
PharmaBiz